Skip to content

The Efficacy of Liposomal Bupivacaine Local Infiltration for Postoperative Analgesia in Elderly Patients Undergoing Lumbar Surgery

The Efficacy of Liposomal Bupivacaine Local Infiltration for Postoperative Analgesia in Elderly Patients Undergoing Lumbar Surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097097
Enrollment
Unknown
Registered
2025-02-12
Start date
2025-02-25
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spine disease

Interventions

Group LB:Liposomal bupivacaine was used to infiltrate analgesia
Group PB:Bupivacaine hydrochloride was used to infiltrate analgesia

Sponsors

he First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1 Patients (2 or more segments) who are scheduled for lumbar surgery 2 Age 60 ~ 85 years old; 3 Gender is not limited; 4 ASA classification is ? ~ ?; 5 BMI 18 ~ 28 kg/m^2; 6 Primary school and above education level

Exclusion criteria

Exclusion criteria: 1 History of central nervous system and mental illness; 2 Severe cardiovascular system, liver and lung dysfunction; 3 Long-term history of sedative and analgesic drugs; 4 Allergic to local anesthesia drugs; 5 Injection site infection.

Design outcomes

Primary

MeasureTime frame
Postoperative pain;

Secondary

MeasureTime frame
Early postoperative recovery;Sleep; Adverse reactions;Chronic pain;

Countries

China

Contacts

Public ContactShudong WANG

The First Affiliated Hospital of University of Science and Technology of China

wy1206@163.com+86 139 6514 7245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026